Psyence Biomedical Ltd.
PBM
$3.48
-$0.08-2.25%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | 0.00% | -148.07% | 0.00% | -2.26% | 0.00% |
| Total Depreciation and Amortization | 0.00% | 0.00% | 0.00% | 8.33% | 0.00% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 0.00% | 201.70% | 0.00% | -182.08% | 0.00% |
| Change in Net Operating Assets | 0.00% | -786.97% | 0.00% | 136.21% | 0.00% |
| Cash from Operations | 0.00% | -201.29% | 0.00% | 8.53% | 0.00% |
| Capital Expenditure | -- | 100.00% | 0.00% | 94.12% | 0.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 0.00% | 87.53% | 0.00% | -62,575.00% | 0.00% |
| Cash from Investing | 0.00% | 87.54% | 0.00% | -40,832.65% | 0.00% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | 0.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 0.00% | -2.08% | 0.00% | 50.47% | 0.00% |
| Cash from Financing | 0.00% | -2.08% | 0.00% | 9.71% | 0.00% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 0.00% | -70.95% | 0.00% | -75.85% | 0.00% |